4-(ChloroMethyl)-N-cyclopentylbenzaMide
![]() |
- $55 - $790
- Product name: 4-(ChloroMethyl)-N-cyclopentylbenzaMide
- CAS: 896906-11-9
- MF: C13H16ClNO
- MW: 237.73
- EINECS:
- MDL Number:MFCD02826241
- Synonyms:4-(ChloroMethyl)-N-cyclopentylbenzaMide;Benzamide, 4-(chloromethyl)-N-cyclopentyl-
4 prices
Selected condition:
Brand
- Chemenu
- Crysdot
- TRC
Package
- 250mg
- 10g
- 25g
- ManufacturerChemenu
- Product numberCM313301
- Product description4-(Chloromethyl)-N-cyclopentylbenzamide 95%
- Packaging10g
- Price$373
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD12013935
- Product description4-(Chloromethyl)-N-cyclopentylbenzamide 95+%
- Packaging10g
- Price$395
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD12013935
- Product description4-(Chloromethyl)-N-cyclopentylbenzamide 95+%
- Packaging25g
- Price$790
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberC427678
- Product description4-(Chloromethyl)-N-cyclopentylbenzamide
- Packaging250mg
- Price$55
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
Chemenu | CM313301 | 4-(Chloromethyl)-N-cyclopentylbenzamide 95% | 10g | $373 | 2021-12-16 | Buy |
Crysdot | CD12013935 | 4-(Chloromethyl)-N-cyclopentylbenzamide 95+% | 10g | $395 | 2021-12-16 | Buy |
Crysdot | CD12013935 | 4-(Chloromethyl)-N-cyclopentylbenzamide 95+% | 25g | $790 | 2021-12-16 | Buy |
TRC | C427678 | 4-(Chloromethyl)-N-cyclopentylbenzamide | 250mg | $55 | 2021-12-16 | Buy |
Properties
Boiling point :413.4±28.0 °C(Predicted)
Density :1.17±0.1 g/cm3(Predicted)
pka :14.42±0.20(Predicted)
Density :1.17±0.1 g/cm3(Predicted)
pka :14.42±0.20(Predicted)
Safety Information
Symbol(GHS): |
![]() ![]() |
|||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Signal word: | Danger | |||||||||||||||||||||||||||||||||||
Hazard statements: |
|
|||||||||||||||||||||||||||||||||||
Precautionary statements: |
|